Literature DB >> 22478986

Should IV Antibiotics Be Administered by Prolonged Infusion?

.   

Abstract

Year:  2010        PMID： 22478986      PMCID： PMC2901786          DOI： 10.4212/cjhp.v63i3.922

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  20 in total

1.  An emotional-based medicine approach to monitoring once-daily aminoglycosides.

Authors:  J P McCormack
Journal:  Pharmacotherapy       Date:  2000-12       Impact factor: 4.705

2.  Pharmacodynamics of cefepime in patients with Gram-negative infections.

Authors:  Vincent H Tam; Peggy S McKinnon; Ronda L Akins; Michael J Rybak; George L Drusano
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

3.  [A preliminary study of the administration of carbapenem antibiotics in sepsis patients on the basis of the administration time].

Authors:  Masahiro Kojika; Nobuhiro Sato; Masanori Hakozaki; Yasusi Suzuki; Gaku Takahasi; Sigeatu Endo; Kenji Suzuki; Go Wakabayasi
Journal:  Jpn J Antibiot       Date:  2005-10

4.  The jury is still out on continuous infusion of beta-lactam antibiotics in intensive care patients.

Authors:  Arthur R H van Zanten
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

5.  Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.

Authors:  Gita Wasan Patel; Nimish Patel; Asma Lat; Kristen Trombley; Sam Enbawe; Kelli Manor; Raymond Smith; Thomas P Lodise
Journal:  Diagn Microbiol Infect Dis       Date:  2009-06       Impact factor: 2.803

6.  A reminder: piperacillin/tazobactam is not for Pseudomonas.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1994-11-25       Impact factor: 1.909

7.  Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.

Authors:  G L Drusano; S L Preston; C Hardalo; R Hare; C Banfield; D Andes; O Vesga; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

Authors:  George G Zhanel; Mel DeCorby; Nancy Laing; Barb Weshnoweski; Ravi Vashisht; Franil Tailor; Kim A Nichol; Aleksandra Wierzbowski; Patricia J Baudry; James A Karlowsky; Philippe Lagacé-Wiens; Andrew Walkty; Melissa McCracken; Michael R Mulvey; Jack Johnson; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

9.  Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.

Authors:  Anthony M Nicasio; Robert E Ariano; Sheryl A Zelenitsky; Aryun Kim; Jared L Crandon; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.

Authors:  Peggy S McKinnon; Joseph A Paladino; Jerome J Schentag
Journal:  Int J Antimicrob Agents       Date:  2008-03-04       Impact factor: 5.283
View more
  2 in total

1.  Should Prolonged Infusion of β-Lactams Become Standard of Practice?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2017 Mar-Apr

Review 2.  Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

Authors:  Jennifer Shiu; Erica Wang; Aaron M Tejani; Michael Wasdell
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.